Novo Nordisk Chief Financial Officer: The improved performance outlook is mainly due to increased expectations for sales of GLP-1 products.

Zhitongcaijing · 1d ago
Novo Nordisk Chief Financial Officer: The improved performance outlook is mainly due to increased expectations for sales of GLP-1 products.